ViraVac: Effective vaccine to lower Covid contracting
Combined with saline it may be used as Covid vaccination, it is squirted up nose
(Web Desk) – Corona virus and now its variants have been causing lots of troubles for people across the globe. Getting the vaccine has been thought of remedy against the virus. But that remedy works after one has been infected with the virus.
But is there any was that people could just reject the virus from entering their bodies through nasal cavities?
A box of white powder created by researchers at Lancaster University may serve as a crucial tool in assisting us in doing just that and is locked up in a lab in Bangladesh.
This is due to the fact that this powder when combined with saline may be used as a Covid-19 vaccination. But unlike the present Covid vaccinations it is squirted up your nose rather than being injected into your arm.
Importantly, this vaccine called ViraVac is hoped to be more effective in lowering the likelihood of contracting an infection in the first place whereas other vaccines lower the risk of catastrophic illness and death.
The ViraVac vaccine is based on one that is sprayed over barns to prevent a coronavirus variant in hens. There are now about a dozen nasal Covid vaccines in development.
One of them is a two-dose nasal vaccination for children that is now being made in India and was created by Washington University in the United States. This vaccine has been licensed in India as both a main and booster vaccine. After testing revealed that the vaccination provided full protection against specific Covid strains after six weeks, the vaccine was awarded emergency approval.
